Metabolic enzymes moonlighting to drive enzalutamide resistance in prostate cancer.
Transl Androl Urol
; 13(4): 626-630, 2024 Apr 30.
Article
in En
| MEDLINE
| ID: mdl-38721296
Full text:
1
Database:
MEDLINE
Language:
En
Journal:
Transl Androl Urol
Year:
2024
Type:
Article
Affiliation country:
Denmark